Trump Bought Stock in Eli Lilly as His Policies Gave the Drugmaker a Big Boost, Documents Show
[ad_1] President Donald Trump has long bantered about GLP-1s, the breakthrough medicines that have changed care for diabetes and obesity. Sometimes he calls them “the fat drug.” In an interview with the The New York Times in January, he mused that “I probably should” take them. A few days before the Times published that story,…